GPs applauded for rapid uptake of hepatitis C cures

More people will be cured of hepatitis C this year than in the previous decade, thanks in part to GPs prescribing the new non-interferon antiviral treatments, experts say.

More than 26,000 people have received treatment with the direct-acting antiviral drugs for hepatitis C since they were listed on the PBS in March 2016, according to Professor Greg Dore, head of viral hepatitis research at the Kirby Institute, University of NSW.

Speaking at the release of a new report on hepatitis C surveillance and treatment, Professor Dore said that prior to 2015, fewer than 3000 people a year were treated for hepatitis C